Juntendo Co., Ltd.

Juntendo Co., Ltd.

TTSE:9835
503.00
JPY
-3.00
(-0.59%)
-37.20EPS
4.13BMarket Cap
Jan 08Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
5,554.95
5,478.91
5,441.71
5,464.37
5,445.71
5,394.91
5,254.1
5,974.11
5,697.61
5,543.34
5,505.62
5,471.75
5,307.44
5,188.28
Basic EPS, GAAP
-27.34
21.84
29.89
29.6
25.65
-1.04
10.77
170.18
74.96
47.16
23.29
18.82
-44.55
-37.2
Free Cash Flow per Basic Share
105.62
156.35
-190.51
12.09
-4.09
-86.09
130.9
488.83
-80.68
-253.06
-98.33
64.49
-108.6
- -
Dividend per Share
8.11
6.25
3.14
7.48
9.98
9.96
9.99
9.96
14.88
14.94
14.95
10
9.98
- -
Book Value per Share
1,277.72
1,298.22
1,288.84
1,316.08
1,332.16
1,318
1,314.57
1,475.34
1,535.4
1,568.82
1,581.78
1,593.76
1,552.5
1,639.27
Tangible Book Value per Share
1,168.53
1,210.99
1,200.9
1,232.64
1,255.09
1,237.05
1,246.82
1,424.76
1,501.69
1,530.94
1,542.07
1,557.25
1,495.11
1,584.97
Basic Weighted Avg Shares
8
8
8
8
8
8
8
8
8
8
8
8
8
8
Sales/Revenue/Turnover
44,848
44,218
43,904
44,078
43,925
43,512
42,376
48,181
46,107
44,965
44,654
44,376
43,041
42,076
Operating Margin (%)
0.62
1.54
1.57
1.3
0.94
0.04
0.69
4.73
2.67
2.02
0.71
1.07
0.55
0.77
Depreciation Expense
1,222
1,119
1,128
1,037
545
1,086
1,201
1,178
1,172
1,197
1,305
1,168
1,242
- -
Net Income, GAAP
-221
176
241
239
207
-8
87
1,372
607
383
189
153
-361
-302
Effective Tax Rate (%)
- -
60.27
47.44
45.35
36.37
162.74
53.05
33.37
40.95
43.92
36.24
41.36
- -
- -
Profit Margin (%)
-0.49
0.4
0.55
0.54
0.47
-0.02
0.21
2.85
1.32
0.85
0.42
0.34
-0.84
-0.72
Working Capital
1,698
-4
2,325
2,630
2,240
2,042
978
2,292
3,277
2,868
3,382
2,671
3,325
3,649
LT Debt
8,581
6,228
8,799
8,594
8,199
9,405
7,625
7,332
7,508
8,793
9,296
9,447
12,643
10,902
Total Equity
10,314
10,477
10,397
10,616
10,745
10,630
10,602
11,898
12,455
12,725
12,829
12,925
12,590
13,294
Return on Invested Capital (%)
- -
1
1.34
1.24
1.12
-0.04
0.56
6.55
3.22
2.09
0.78
1.03
- -
- -
Return on Capital (%)
- -
0.96
1.26
1.3
1.27
-0.35
0.56
6.26
2.9
1.73
0.91
0.76
- -
- -
Return on Common Equity (%)
-2.11
1.7
2.31
2.27
1.94
-0.08
0.82
12.2
4.98
3.04
1.48
1.19
-2.83
- -

Capital Structure

JPY

•

in mil. unless spec.
Feb'26
May'27
Aug'27
ST Debt
4,421
6,870
3,454
LT Borrowings
11,577
10,998
10,902
LT Finance Leases
1,066
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
4,217
4,079
4,128

Working Capital

JPY

•

in mil. unless spec.
Feb'26
May'27
Aug'27
Total Current Assets
16,157
17,856
16,095
Cash, Cash Equivalents & STI
1,853
2,554
1,258
Accounts Receivable, Net
451
883
621
Inventories
13,231
13,784
13,547
Total Current Liabilities
12,832
14,602
12,446
Payables & Accruals
- -
- -
- -
ST Debt
4,421
6,870
3,454
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.01%
1.17%
-2.59%
Free Cash Flow
138.64%
-79.46%
-268.39%
Net Income, GAAP
-27.52%
-99.86%
-336.75%
Sales/Revenue/Turnover
-0.09%
-2.22%
-3.01%
Total Cash Common Dividend
18.88%
3.45%
-0.15%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
12,219
224
10,274
33,663
44,376
2026
12,245
11,243
-12,738
32,291
43,041
2027
11,959
10,564
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
38.3
30.58
-15.07
-34.99
18.82
2026
39.58
31.03
-22.31
-92.86
-44.55
2027
45.03
32.93
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
10
2026
- -
- -
- -
- -
9.98
2027
- -
- -
- -
- -
- -

Company Description

CEO
Tadashi Iizuka
Full Time Employees
555
Sector
Retail trade
Industry
Home improvement chains
Address
2179-1, Toda-cho Masuda SM Japan 699-3676
IPO Date
Mar 1, 1989
Business
Juntendo Co., Ltd., founded in 1951 and headquartered in Tokyo, Japan, operates primarily in the healthcare and pharmaceutical sectors. The company offers an extensive range of products and services including pharmaceutical manufacturing and sales; hospital and healthcare services; medical device production; clinical research and laboratory testing; and health and wellness support services. Juntendo serves both B2B clients such as hospitals and clinics, as well as end consumers primarily within Japan but with expanding regional operations. In the last 1-2 years, Juntendo has focused on strategic expansion in healthcare services by forming partnerships with technology firms to enhance digital healthcare solutions and integrating advanced medical devices and AI diagnostics into their service offerings. There have been notable investments in clinical research capacities and launches of new pharmaceuticals aimed at chronic and lifestyle diseases. The company is also advancing its health management and wellness programs as part of a broader shift towards holistic healthcare provision. Juntendo operates mainly in Japan but is increasing its footprint across Asia through alliances and joint ventures, supporting growth in pharmaceutical sales and medical services. The company maintains a strong research and development focus, underpinned by its foundation over 70 years ago. No recent name changes or major reorganizations have been reported. Overall, Juntendo Co., Ltd. combines pharmaceutical manufacturing, hospital and healthcare operations, clinical research, medical device production, and health management services into a comprehensive healthcare corporation positioned for growth through innovation and strategic collaborations.